News

Healthcare

AP News | Equities.com |

As many as 215,000 more people than usual died in the U.S. during the first seven months of 2020, suggesting that the number of lives lost to the coronavirus is significantly higher than the official toll. And half the dead were people of color — Blacks, Hispanics, Native Americans and, to a marked degree unrecognized until now, Asian Americans.

The new figures from the Centers for Disease Control and Prevention highlight a stark disparity: Deaths among minorities during the crisis have risen far more than they have among whites.

As of the end of July, the official death toll in the U.S. from COVID-19 was about 150,000. It has since grown to over 170,000.


Reuters | Equities.com |

Novartis on Thursday won U.S. Food and Drug Administration (FDA) approval to repurpose an 11-year-old blood cancer drug against multiple sclerosis as the Swiss drugmaker takes on rival Roche’s big-selling Ocrevus for the autoimmune disorder.

The FDA approved Kesimpta, known generically as ofatumumab or by its brand name Arzerra, for use against chronic lymphocytic leukemia (CLL), to treat patients with relapsing multiple sclerosis. Arzerra was approved for CLL in 2009, and is sold by Novartis under a licensing deal with Genmab.


Reuters | Equities.com |

Johnson & Johnson on Wednesday agreed to pay about $6.5 billion in cash to buy Momenta Pharmaceuticals Inc in a deal aimed at expanding its portfolio of autoimmune disease treatments.

The deal gives J&J’s Janssen unit access to Momenta’s experimental therapy, nipocalimab, being tested for myasthenia gravis, a neuromuscular disease that causes weakness in muscles, and other diseases where the immune system attacks the body.

J&J hopes to get the drug approved to treat several conditions and eventually bring in blockbuster sales, as the company bulks up its pharmaceuticals unit, its largest business.


AP News | Equities.com |

Helena Miller listened to teachers, terrified to reenter classrooms, and parents, exhausted from trying to make virtual learning work at home. She heard from school officials who spent hundreds of hours on thousands of details — buses, classrooms, football, arts, special education. She spent countless nights, eyes wide open, her mind wrestling over the safety and education of the 17,000 children she swore to protect.

She thought of...


Reuters | Equities.com |

Johnson & Johnson could produce 1 billion doses of its potential COVID-19 vaccine next year if it proves successful and would consider injecting healthy volunteers with the novel coronavirus if there are not enough patients for final trials, a company executive said.

J&J kicked off in July early-stage human safety trials for its potential COVID-19 vaccine after releasing details of a study in monkeys that showed i...


AP News | Equities.com |

Vilified, threatened with violence and in some cases suffering from burnout, dozens of state and local public health officials around the U.S. have resigned or have been fired amid the coronavirus outbreak, a testament to how politically combustible masks, lockdowns and infection data have become.

The latest departure came Sunday, when California’s public health director, Dr. Sonia Angell, quit without explanation following a technical glitch that caused a delay in reporting virus test results — information used to make decisions about reopening businesses and schools.


Reuters | Equities.com |

The global death toll from the coronavirus surpassed 700,000 on Wednesday, according to a Reuters tally, with the United States, Brazil, India and Mexico leading the rise in fatalities.

Nearly 5,900 people are dying every 24 hours from COVID-19 on average, according to Reuters calculations based on data from the past two weeks.

That equates to 247 people per hour, or one person every 15 seconds.

President Donald Trump said t...


AP News | Equities.com |

The Trump administration’s plan to provide every nursing home with a fast COVID-19 testing machine comes with an asterisk: The government won’t supply enough test kits to check staff and residents beyond an initial couple of rounds.

A program that sounded like a game changer when it was announced last month at the White House is now prompting concerns that it could turn into another unfulfilled promise for nursing homes, whose...


AP News | Equities.com |

Germany-based Siemens Healthineers said Sunday it will buy U.S. cancer therapy and research company Varian in a deal worth around $16.4 billion.

Siemens Healthineers, in which industrial conglomerate Siemens holds a majority stake, said it will buy all shares in Varian Medical Systems, Inc. for $177.50 per share in cash.

It said that the acquisition is expected to close in the first half of 2021, and requires the approval of regulators and Varian shareho...


AP News | Equities.com |

The coronavirus transformed Florida’s nursing homes into closely guarded fortresses beginning in March, with the state banning family visits, isolating infected residents in separate wings and now requiring staff be tested every two weeks. But the explosion of cases statewide is proving that is not enough.

The numbers are already showing the grim reality, underscoring how mask compliance and restrictions in the outside worl...